Transporter Associated With Antigen Processing (TAP) 1 Gene Polymorphisms and Risks of Urothelial Cell Carcinoma Among the Japanese Population
View abstract on PubMed
Summary
This summary is machine-generated.Certain gene variations in the transporter associated with antigen processing 1 (TAP1) gene increase the risk of urothelial cell carcinoma in Japanese females. Smoking did not correlate with these genetic risks.
Area Of Science
- Oncology
- Genetics
- Molecular Biology
Background
- Urothelial cell carcinoma (UCC) is a costly cancer due to high recurrence rates and treatment complications.
- Genetic factors, including gene polymorphisms, are implicated in UCC development.
- The transporter associated with antigen processing 1 (TAP1) gene plays a role in immune response and antigen presentation.
Purpose Of The Study
- To investigate the association between two single-nucleotide polymorphisms (SNPs) in the TAP1 gene and the risk of developing urothelial cell carcinoma.
- To analyze these genetic variations in the Japanese population.
Main Methods
- Genotyping of two TAP1 gene polymorphisms (I333V and D637G) using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP).
- Statistical analysis, including calculation of adjusted odds ratios (OR) with 95% confidence intervals (CI).
Main Results
- Females with mutant genotypes (A/G+G/G) for TAP1 I333V and D637G polymorphisms showed significantly increased odds of developing UCC (OR=2.28 and OR=2.50, respectively).
- A higher likelihood of UCC was observed in females with the (A/G+G/G) genotype compared to the A/A genotype.
- No significant correlation was found between smoking status and TAP1 gene polymorphisms in relation to UCC risk.
Conclusions
- TAP1 gene polymorphisms are associated with an increased risk of urothelial cell carcinoma in females.
- These findings highlight the role of specific genetic variations in UCC susceptibility, particularly in the female Japanese population.
- Further research may explore targeted genetic screening or therapeutic strategies based on these polymorphisms.
Related Concept Videos
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

